| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |